Empagliflozin Benefits Tied to Drop in NT-proBNP Levels in Patients With Heart Failure Empagliflozin Benefits Tied to Drop in NT-proBNP Levels in Patients With Heart Failure

Empagliflozin reduced the risk of adverse cardiovascular and renal outcomes in heart failure patients regardless of baseline NT-proBNP levels, researchers say.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Cardiology News Source Type: news